Paulo Feijó Barroso

Instituição:

Universidade Federal do Rio de Janeiro

Centro:

Centro de Ciências da Saúde

Unidade:

Faculdade de Medicina

Departamento:

Departamento de Medicina Preventiva/FM

ORCID:

https://orcid.org/0000-0002-6672-578X


Formação:

  • Johns Hopkins University

    Controle de Doenças Infecciosas- E. Saúde Pública | Doutorado | 1994 - 1999

  • Universidade Federal do Rio de Janeiro

    Medicina | Mestrado | 1986 - 1992

  • Universidade Federal do Rio de Janeiro

    Medicina | Graduação | 1978 - 1983
Laboratórios:
Nenhum laboratório cadastrado
Nuvens de Palavras:
Artigos:
Nenhum artigo cadastrado
Eventos:

(0.00% eventos com DOI)

Titulo DOI Ano
Identification of Risk Factors for Recent HIV-1 Infection in a HIV Testing Site in Rio de Janeiro, Brazil. 2007
Barriers to recruit female commercial sex workers for HIV vaccine trials: The Rio de Janeiro Experience 2007
Course of human immunodeficiency virus type 1 infection after seroconversion in a cohort of men who have sex with men (MSM) in Rio de Janeiro, Brazil. 2005
Generic drugs, health delivery mode and effectiveness of HAART in Brazil 2005
Recruitment of a high-risk heterosexual cohort for HIV vaccine efficacy trials in Rio de Janeiro, Brazil: Risk profile and willingness to participate in vaccine trials 2004
Recruitment and retention of a high-risk heterosexual cohort for HIV vaccine efficacy trials in Rio de Janeiro, Brazil: risk profile and willingness to participate in vaccine trials 2004
May SB, Cardos GC, Costa ER, Barroso PF. High adherence rates to antiretrovirals in a resource-poor setting. Determinants of adherence to antiretroviral therapy in a developing country. 2003
Sexual activity after initiation of antiretroviral therapy in Brazil 2002
Dynamics of HIV replication in semen compartment is higher than that in blood compartment 2001
Rebound of seminal HIV-1 viral load associated with sexually transmitted diseases after virologic suppression by antiretroviral therapy 2000
Predictors of seminal viral load suppression in subjects starting antiretroviral therapy 2000
Adherence to antiretroviral therapy is associated with seminal viral load suppression in subjects starting antiretroviral therapy 1999
Seminal HIV-1 shedding is increased by the presence of genital warts 1999
Seminal HIV-1 is reduced by antiretroviral therapy and is correlated with plasma HIV-1 viral load 1999
High correlation between plasma and seminal HIV-1 viral load in antiretroviral naive Brazilian subjects 1998
Impact of antiretroviral therapy on HIV-1 seminal viral load 1998
Investigation of enteropathogens in 81 HIV-infected patients in Rio de Janeiro, Brasil 1993
Publicações:
Minha Rede: